[Small cell lung cancer].
Yoneda
Shuichi
S
Department of Pulmonary Medicine, Saitama Cancer Center.
Sakai
Hiroshi
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary / Q000628:therapy; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018288:Carcinoma, Small Cell / Q000175:diagnosis / Q000556:secondary / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D006801:Humans; D000077146:Irinotecan; D015624:Lambert-Eaton Myasthenic Syndrome / Q000209:etiology / Q000628:therapy; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000209:etiology / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin